Clinical Trial Update: Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing RC28-E to aflibercept for efficacy and safety in diabetic macular edema is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• RC28-E

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Diabetic Macular Edema | Phase 3 | Status: RECRUITING